103 related articles for article (PubMed ID: 29021025)
1. ERRATUM.
Furutani A; Sowa Y; Fujiwara H; Otsuji E; Sakai T
Oncol Res; 2016 Jan; 23(1):87. PubMed ID: 29021025
[TBL] [Abstract][Full Text] [Related]
2. The novel HDAC inhibitor OBP-801/YM753 enhances the effects of 5-fluorouracil with radiation on esophageal squamous carcinoma cells.
Furutani A; Sowa Y; Fujiwara H; Otsuji E; Sakai T
Oncol Res; 2014; 21(5):281-6. PubMed ID: 24854104
[TBL] [Abstract][Full Text] [Related]
3. Combination of a novel HDAC inhibitor OBP-801/YM753 and a PI3K inhibitor LY294002 synergistically induces apoptosis in human endometrial carcinoma cells due to increase of Bim with accumulation of ROS.
Yoshioka T; Yogosawa S; Yamada T; Kitawaki J; Sakai T
Gynecol Oncol; 2013 May; 129(2):425-32. PubMed ID: 23403163
[TBL] [Abstract][Full Text] [Related]
4. Three Combined Treatments, a Novel HDAC Inhibitor OBP-801/YM753, 5-Fluorouracil, and Paclitaxel, Induce G₂ Phase Arrest Through the p38 Pathway in Human Ovarian Cancer Cells.
Akiyama M; Sowa Y; Taniguchi T; Watanabe M; Yogosawa S; Kitawaki J; Sakai T
Oncol Res; 2017 Sep; 25(8):1245-1252. PubMed ID: 28117030
[TBL] [Abstract][Full Text] [Related]
5. A novel HDAC inhibitor OBP-801 and a PI3K inhibitor LY294002 synergistically induce apoptosis via the suppression of survivin and XIAP in renal cell carcinoma.
Yamada T; Horinaka M; Shinnoh M; Yoshioka T; Miki T; Sakai T
Int J Oncol; 2013 Oct; 43(4):1080-6. PubMed ID: 23900601
[TBL] [Abstract][Full Text] [Related]
6. YM753, a novel histone deacetylase inhibitor, exhibits antitumor activity with selective, sustained accumulation of acetylated histones in tumors in the WiDr xenograft model.
Shindoh N; Mori M; Terada Y; Oda K; Amino N; Kita A; Taniguchi M; Sohda KY; Nagai K; Sowa Y; Masuoka Y; Orita M; Sasamata M; Matsushime H; Furuichi K; Sakai T
Int J Oncol; 2008 Mar; 32(3):545-55. PubMed ID: 18292931
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitors sensitize 5-fluorouracil-resistant MDA-MB-468 breast cancer cells to 5-fluorouracil.
Minegaki T; Suzuki A; Mori M; Tsuji S; Yamamoto S; Watanabe A; Tsuzuki T; Tsunoda T; Yamamoto A; Tsujimoto M; Nishiguchi K
Oncol Lett; 2018 Nov; 16(5):6202-6208. PubMed ID: 30333885
[TBL] [Abstract][Full Text] [Related]
8. Combination of the histone deacetylase inhibitor depsipeptide and 5-fluorouracil upregulates major histocompatibility complex class II and p21 genes and activates caspase-3/7 in human colon cancer HCT-116 cells.
Okada K; Hakata S; Terashima J; Gamou T; Habano W; Ozawa S
Oncol Rep; 2016 Oct; 36(4):1875-85. PubMed ID: 27509880
[TBL] [Abstract][Full Text] [Related]
9. The histone deacetylase inhibitor OBP-801 and eribulin synergistically inhibit the growth of triple-negative breast cancer cells with the suppression of survivin, Bcl-xL, and the MAPK pathway.
Ono H; Sowa Y; Horinaka M; Iizumi Y; Watanabe M; Morita M; Nishimoto E; Taguchi T; Sakai T
Breast Cancer Res Treat; 2018 Aug; 171(1):43-52. PubMed ID: 29752686
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells.
Lee JH; Park JH; Jung Y; Kim JH; Jong HS; Kim TY; Bang YJ
Mol Cancer Ther; 2006 Dec; 5(12):3085-95. PubMed ID: 17172411
[TBL] [Abstract][Full Text] [Related]
11. Suberoylanilide hydroxamic acid enhances chemosensitivity to 5-fluorouracil in hepatocellular carcinoma via inhibition of thymidylate synthase.
Liao B; Liang H; Chen J; Liu Q; Zhang B; Chen X
Tumour Biol; 2015 Dec; 36(12):9347-56. PubMed ID: 26108995
[TBL] [Abstract][Full Text] [Related]
12. The HDAC inhibitor OBP-801 suppresses the growth of myxofibrosarcoma cells.
Kawarazaki A; Horinaka M; Yasuda S; Kawashima H; Numajiri T; Sakai T
J BUON; 2020; 25(1):464-471. PubMed ID: 32277670
[TBL] [Abstract][Full Text] [Related]
13. Changes in thymidylate synthase and its inhibition rate and changes in dihydropyrimidine dehydrogenase after the administration of 5-fluorouracil with cisplatin to nude mice with gastric cancer xenograft SC-1-NU.
Sakurai Y; Uraguchi T; Imazu H; Hasegawa S; Matsubara T; Ochiai M; Funabiki T
Gastric Cancer; 2004; 7(2):110-6. PubMed ID: 15224198
[TBL] [Abstract][Full Text] [Related]
14. Combination of SNX-2112 with 5-FU exhibits antagonistic effect in esophageal cancer cells.
Liu Y; Wang X; Wang Y; Zhang Y; Zheng K; Yan H; Zhang L; Chen W; Wang X; Liu Q; Wang S; Wang Y
Int J Oncol; 2015 Jan; 46(1):299-307. PubMed ID: 25333998
[TBL] [Abstract][Full Text] [Related]
15. FGFR inhibitor BGJ398 and HDAC inhibitor OBP-801 synergistically inhibit cell growth and induce apoptosis in bladder cancer cells.
Takamura T; Horinaka M; Yasuda S; Toriyama S; Aono Y; Sowa Y; Miki T; Ukimura O; Sakai T
Oncol Rep; 2018 Feb; 39(2):627-632. PubMed ID: 29207153
[TBL] [Abstract][Full Text] [Related]
16. Sequential treatment with SN-38 followed by 5-fluorouracil shows synergistic cytotoxic activity in small cell lung cancer cells.
Takeda K; Suyama H; Igishi T; Shigeoka Y; Matsumoto S; Yamasaki A; Hashimoto K; Sumikawa T; Morita M; Ueda Y; Shimizu E
Oncol Rep; 2008 Apr; 19(4):945-51. PubMed ID: 18357380
[TBL] [Abstract][Full Text] [Related]
17. Effect of histone deacetylase inhibitor in combination with 5-fluorouracil on pancreas cancer and cholangiocarcinoma cell lines.
Iwahashi S; Ishibashi H; Utsunomiya T; Morine Y; Ochir TL; Hanaoka J; Mori H; Ikemoto T; Imura S; Shimada M
J Med Invest; 2011 Feb; 58(1-2):106-9. PubMed ID: 21372494
[TBL] [Abstract][Full Text] [Related]
18. Chidamide and 5-flurouracil show a synergistic antitumor effect on human colon cancer xenografts in nude mice.
Liu L; Qiu S; Liu Y; Liu Z; Zheng Y; Su X; Chen B; Chen H
Neoplasma; 2016; 63(2):193-200. PubMed ID: 26774139
[TBL] [Abstract][Full Text] [Related]
19. Lapatinib, a dual inhibitor of EGFR and HER2, has synergistic effects with 5-fluorouracil on esophageal carcinoma.
Guo XF; Zhu XF; Zhong GS; Deng BG; Gao ZT; Wang H
Oncol Rep; 2012 May; 27(5):1639-45. PubMed ID: 22293713
[TBL] [Abstract][Full Text] [Related]
20. β-Carotene synergistically enhances the anti-tumor effect of 5-fluorouracil on esophageal squamous cell carcinoma in vivo and in vitro.
Zhang Y; Zhu X; Huang T; Chen L; Liu Y; Li Q; Song J; Ma S; Zhang K; Yang B; Guan F
Toxicol Lett; 2016 Nov; 261():49-58. PubMed ID: 27586268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
